Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199955 (US9227930, 202) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199969 (BDBM199971 | US9227930, 209a) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199969 (BDBM199971 | US9227930, 209a) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199970 (US9227930, 210) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199952 (US9227930, 199) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199953 (US9227930, 200) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199954 (US9227930, 201) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199958 (US9227930, 205) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199950 (US9227930, 197) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199962 (US9227930, 206) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199957 (US9227930, 204) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199956 (US9227930, 203) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199948 (US9227930, 195) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199963 (US9227930, 207) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199951 (US9227930, 198) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A) (Homo sapiens (Human)) | BDBM199949 (US9227930, 196) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG US Patent | Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171... | US Patent US9227930 (2016) BindingDB Entry DOI: 10.7270/Q2DZ0737 | |||||||||||
More data for this Ligand-Target Pair |